CANCER THERAPY WITH AN ONCOLYTIC VIRUS COMBINED WITH A CHECKPOINT INHIBITOR

The present invention concerns a pharmaceutical composition where a checkpoint inhibitor is combined with an oncolytic virus and the use of said combination for the treatment of cancer. La presente invención se refiere a una composición farmacéutica en la que se combina un inhibidor de punto de cont...

Full description

Saved in:
Bibliographic Details
Main Authors Barbara LEUCHS, Dirk JÄGER, Jean ROMMELAERE, Assia ANGELOVA, Michael DAHM, Antonio MARCHINI, Wolfgang WICK
Format Patent
LanguageEnglish
Spanish
Published 14.01.2019
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention concerns a pharmaceutical composition where a checkpoint inhibitor is combined with an oncolytic virus and the use of said combination for the treatment of cancer. La presente invención se refiere a una composición farmacéutica en la que se combina un inhibidor de punto de control con un virus oncolítico y el uso de dicha combinación para el tratamiento del cáncer.
Bibliography:Application Number: MX20180010709